Utah Medical Products, Inc. (UTMD)
69.16
-1.94
(-2.73%)
USD |
NASDAQ |
Sep 08, 16:00
67.99
-1.17
(-1.69%)
Pre-Market: 20:00
Utah Medical Products Gross Profit Margin (Quarterly) : 55.60% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 55.60% |
| March 31, 2026 | 55.26% |
| December 31, 2025 | 52.31% |
| September 30, 2025 | 51.56% |
| June 30, 2025 | 50.80% |
| March 31, 2025 | 51.79% |
| December 31, 2024 | 52.48% |
| September 30, 2024 | 52.74% |
| June 30, 2024 | 55.22% |
| March 31, 2024 | 55.14% |
| December 31, 2023 | 50.51% |
| September 30, 2023 | 45.92% |
| June 30, 2023 | 47.63% |
| March 31, 2023 | 49.90% |
| December 31, 2022 | 49.71% |
| September 30, 2022 | 50.99% |
| June 30, 2022 | 48.70% |
| March 31, 2022 | 47.77% |
| December 31, 2021 | 50.05% |
| September 30, 2021 | 51.00% |
| June 30, 2021 | 48.51% |
| March 31, 2021 | 48.18% |
| December 31, 2020 | 46.84% |
| September 30, 2020 | 46.42% |
| June 30, 2020 | 37.99% |
| Date | Value |
|---|---|
| March 31, 2020 | 47.75% |
| December 31, 2019 | 52.25% |
| September 30, 2019 | 46.17% |
| June 30, 2019 | 49.54% |
| March 31, 2019 | 51.27% |
| December 31, 2018 | 57.18% |
| September 30, 2018 | 55.43% |
| June 30, 2018 | 58.75% |
| March 31, 2018 | 58.48% |
| December 31, 2017 | 57.67% |
| September 30, 2017 | 59.00% |
| June 30, 2017 | 58.94% |
| March 31, 2017 | 58.88% |
| December 31, 2016 | 55.85% |
| September 30, 2016 | 54.39% |
| June 30, 2016 | 54.15% |
| March 31, 2016 | 54.82% |
| December 31, 2015 | 54.49% |
| September 30, 2015 | 54.84% |
| June 30, 2015 | 58.59% |
| March 31, 2015 | 53.76% |
| December 31, 2014 | 62.36% |
| September 30, 2014 | 51.40% |
| June 30, 2014 | 53.90% |
| March 31, 2014 | 54.62% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 52.64% |
| AngioDynamics, Inc. | 50.87% |
| Alphatec Holdings, Inc. | 62.90% |
| AtriCure, Inc. | 76.75% |
| Baxter International, Inc. | 33.55% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 8.78% |
| Return on Assets | 8.54% |
| Return on Invested Capital | 8.76% |
| Profit Margin (Quarterly) | 31.49% |
| Operating Margin (Quarterly) | 31.06% |
| Return on Net Operating Assets | 28.31% |